Aida Pharmaceuticals Pink Sheet Forward View - Simple Regression
| AIDA Stock | USD 0.0003 0.00 0.00% |
Aida Pink Sheet outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Aida Pharmaceuticals stock prices and determine the direction of Aida Pharmaceuticals's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Aida Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the relative strength index (rsi) of Aida Pharmaceuticals' share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Aida Pharmaceuticals hype-based prediction, you can estimate the value of Aida Pharmaceuticals from the perspective of Aida Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Aida Pharmaceuticals on the next trading day is expected to be 0.0003 with a mean absolute deviation of 0.000021 and the sum of the absolute errors of 0. Aida Pharmaceuticals after-hype prediction price | USD 3.25E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aida |
Aida Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Aida price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aida using various technical indicators. When you analyze Aida charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Aida Pharmaceuticals Simple Regression Price Forecast For the 7th of February
Given 90 days horizon, the Simple Regression forecasted value of Aida Pharmaceuticals on the next trading day is expected to be 0.0003 with a mean absolute deviation of 0.000021, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Aida Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Aida Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Aida Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Aida Pharmaceuticals | Aida Pharmaceuticals Price Prediction | Research Analysis |
Aida Pharmaceuticals Forecasted Value
In the context of forecasting Aida Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Aida Pharmaceuticals' downside and upside margins for the forecasting period are 0.000003 and 6.30, respectively. We have considered Aida Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Aida Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Aida Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 96.942 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0908 |
| SAE | Sum of the absolute errors | 0.0013 |
Predictive Modules for Aida Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aida Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aida Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aida Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Aida Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aida Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Aida Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aida Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Aida Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aida Pharmaceuticals' historical news coverage. Aida Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 6.30, respectively. We have considered Aida Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aida Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Aida Pharmaceuticals is based on 3 months time horizon.
Aida Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Aida Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aida Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aida Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.79 | 6.30 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0003 | 0.0003 | 8.45 |
|
Aida Pharmaceuticals Hype Timeline
Aida Pharmaceuticals is presently traded for 0.0003. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aida is forecasted to increase in value after the next headline, with the price projected to jump to 3.25E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is estimated to be 8.45%, whereas the daily expected return is presently at 0.79%. The volatility of related hype on Aida Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has return on total asset (ROA) of 0.0662 % which means that it generated a profit of $0.0662 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0179) %, meaning that it created substantial loss on money invested by shareholders. Aida Pharmaceuticals' management efficiency ratios could be used to measure how well Aida Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Aida Pharmaceuticals to cross-verify your projections.Aida Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Aida Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Aida Pharmaceuticals' future price movements. Getting to know how Aida Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aida Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| WUHN | Wuhan General Gr | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 300.00 | |
| UPPR | Upper Street Marketing | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MJNE | MJ Holdings | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPLM | Sentry Petroleum | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SYUP | ANBC INC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BLMS | Bloomios | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PANC | Panacos Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CENBF | CEN Biotech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BTTX | Better Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CANQF | CanaQuest Medical Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Aida Pharmaceuticals
For every potential investor in Aida, whether a beginner or expert, Aida Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aida Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aida. Basic forecasting techniques help filter out the noise by identifying Aida Pharmaceuticals' price trends.Aida Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aida Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Aida Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aida Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aida Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Aida Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aida Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aida Pharmaceuticals pink sheet market strength indicators, traders can identify Aida Pharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 3.0E-4 | |||
| Day Typical Price | 3.0E-4 |
Aida Pharmaceuticals Risk Indicators
The analysis of Aida Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aida Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aida pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.49 | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Aida Pharmaceuticals
The number of cover stories for Aida Pharmaceuticals depends on current market conditions and Aida Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aida Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aida Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Aida Pink Sheet
Aida Pharmaceuticals financial ratios help investors to determine whether Aida Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aida with respect to the benefits of owning Aida Pharmaceuticals security.